Established in 2015 and based in Houston Texas, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies that will lead to the development of therapeutics for treatment of cancer. (QIA was established in 2005. Headquartered in Doha, it was founded as a means to strengthen the country's economy. the fund predominantly invests in international markets United States, Europe and Asia-Pacific and within Qatar outside the energy sector.) More details here.
Qatar Investment Authority is listed in the Middle East Investors Directory with the code BD44.
Previous Post: Saudi investors of PIF to invest $1 billion in US car maker Lucid
Next Post: Saudi Arabian firm acquired Ukrainian farming company Mriya